{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:15:11Z","timestamp":1715645711648},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1161\/strokeaha.119.028325","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T10:00:26Z","timestamp":1576144826000},"update-policy":"http:\/\/dx.doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Letter by Romoli Regarding Article, \u201cAntithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis\u201d"],"prefix":"10.1161","volume":"51","author":[{"given":"Michele","family":"Romoli","sequence":"first","affiliation":[{"name":"Neurology Unit, Department of Medicine, Rimini \u201cInfermi\u201d Hospital, AUSL Romagna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.026512"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000017498.88393.44"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813959"},{"key":"e_1_3_2_5_2","first-page":"1","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.","volume":"4422","author":"Kasner SE","year":"2018","unstructured":"Kasner, SE, Swaminathan, B, Lavados, P, Sharma, M, Muir, K, Veltkamp, R, et al. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol. 2018;4422:1\u20138.","journal-title":"Lancet Neurol"},{"key":"e_1_3_2_6_2","first-page":"94","article-title":"Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial.","volume":"18","author":"Shariat A","year":"2013","unstructured":"Shariat, A, Yaghoubi, E, Farazdaghi, M, Aghasadeghi, K, Borhani Haghighi, A. Comparison of medical treatments in cryptogenic stroke patients with patent foramen ovale: a randomized clinical trial. J Res Med Sci. 2013;18:94\u201398.","journal-title":"J Res Med Sci"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.119.028325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:29:13Z","timestamp":1715614153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.119.028325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1161\/STROKEAHA.119.028325"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.119.028325","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"2019-12-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}